Flupirtine protects neurons against excitotoxic or ischemic damage and inhibits the increase in cytosolic Ca2+ concentration
- PMID: 8750707
- DOI: 10.1016/0014-2999(95)00570-6
Flupirtine protects neurons against excitotoxic or ischemic damage and inhibits the increase in cytosolic Ca2+ concentration
Abstract
We tested the effect of flupirtine against ischemic and excitotoxic neuronal damage as well as on the glutamate-induced rise in cytosolic calcium ion concentration (= [Ca2+]i). For in vivo experiments we used a model of focal cerebral ischemia in mice. The middle cerebral artery was permanently occluded and 48 h afterwards brain tissue was stained with neutral red, perfusion-fixed and the infarct surface was determined planimetrically. Pretreatment with flupirtine significantly reduced the infarct area (controls: 24.3 +/- 4.8 mm2, 1 mg/kg flupirtine: 20.1 +/- 3.6 mm2 and 10 mg/kg flupirtine: 19.5 +/- 3.9 mm2; P < 0.05), whereas postischemic application of flupirtine failed to reduce the infarct area. For in vitro studies, primary neuronal cultures were prepared from the hippocampi of newborn rats and excitotoxic damage was induced by exposing the cells to 500 mu M L-glutamate for 30 min. We could demonstrate that flupirtine (1-10 microM) was capable of protecting neurons against glutamate-induced cytotoxicity. In order to elucidate the underlying mechanism of action, we tested the effect of flupirtine on the glutamate-induced rise in [Ca2+]i using the Ca2+-indicator fura-2. L-Glutamate added in a final concentration of 100 microM to the cultured cells for 16 s caused a rise in [Ca2+]i from about 100 nM to 900 nM. Flupirtine (0.1-10 microM) reduced the glutamate-induced rise in [Ca2+]i concentration dependently.
Similar articles
-
Clenbuterol protects mouse cerebral cortex and rat hippocampus from ischemic damage and attenuates glutamate neurotoxicity in cultured hippocampal neurons by induction of NGF.Brain Res. 1996 Apr 22;717(1-2):44-54. doi: 10.1016/0006-8993(95)01567-1. Brain Res. 1996. PMID: 8738252
-
Pharmacological intervention in age-associated brain disorders by Flupirtine: Alzheimer's and prion diseases.Mech Ageing Dev. 1998 Mar 16;101(1-2):1-19. doi: 10.1016/s0047-6374(97)00152-8. Mech Ageing Dev. 1998. PMID: 9593309
-
S-100beta protects cultured neurons against glutamate- and staurosporine-induced damage and is involved in the antiapoptotic action of the 5 HT(1A)-receptor agonist, Bay x 3702.Brain Res. 2000 Mar 6;858(1):121-8. doi: 10.1016/s0006-8993(99)02438-5. Brain Res. 2000. PMID: 10700604
-
Flupirtine, a nonopioid centrally acting analgesic, acts as an NMDA antagonist.Gen Pharmacol. 1998 Mar;30(3):255-63. doi: 10.1016/s0306-3623(97)00355-8. Gen Pharmacol. 1998. PMID: 9510072 Review.
-
Pharmacological studies supporting the therapeutic use of Ginkgo biloba extract for Alzheimer's disease.Pharmacopsychiatry. 2003 Jun;36 Suppl 1:S8-14. doi: 10.1055/s-2003-40454. Pharmacopsychiatry. 2003. PMID: 13130383 Review.
Cited by
-
Efficacy of flupirtine for postoperative pain: A systematic review and meta-analysis.Indian J Anaesth. 2023 Mar;67(3):247-255. doi: 10.4103/ija.ija_599_22. Epub 2023 Mar 16. Indian J Anaesth. 2023. PMID: 37250521 Free PMC article.
-
Brain Distribution and Metabolism of Flupirtine, a Nonopioid Analgesic Drug with Antiseizure Effects, in Neonatal Rats.Pharmaceutics. 2018 Dec 16;10(4):281. doi: 10.3390/pharmaceutics10040281. Pharmaceutics. 2018. PMID: 30558371 Free PMC article.
-
Disease Modification in Multiple Sclerosis by Flupirtine-Results of a Randomized Placebo Controlled Phase II Trial.Front Neurol. 2018 Oct 9;9:842. doi: 10.3389/fneur.2018.00842. eCollection 2018. Front Neurol. 2018. PMID: 30356868 Free PMC article.
-
Anticonvulsant effect of flupirtine in an animal model of neonatal hypoxic-ischemic encephalopathy.Neuropharmacology. 2017 Sep 1;123:126-135. doi: 10.1016/j.neuropharm.2017.06.002. Epub 2017 Jun 3. Neuropharmacology. 2017. PMID: 28587899 Free PMC article.
-
The indirect NMDAR inhibitor flupirtine induces sustained post-ischemic recovery, neuroprotection and angioneurogenesis.Oncotarget. 2015 Jun 10;6(16):14033-44. doi: 10.18632/oncotarget.4226. Oncotarget. 2015. PMID: 26050199 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous